Healthtech Late Stage Investors & VC Firms

847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
HB HBM Partners DDDUFDFD5 people	88🔒	Zug	CH	Pre-Seed–Late Stage	$5M – $50M	+ Add to CRM
HE Health2047 Capital Partners LLC DGGCRBRL5 people	88🔒	Menlo Park	US	Seed–Late Stage	—	+ Add to CRM
MU Mubadala Capital KACGJEMJ5 people · Leads rounds	88🔒	London	AE	Series A–Late Stage	$1M – $50M	+ Add to CRM
NE NewMargin Ventures YHCTHHHK5 people	88🔒	Shanghai	CN	Pre-Seed–Late Stage	$425K – $200M	+ Add to CRM
SE Sectoral Asset Management MSFBMMCP8 people	88🔒	Montreal	CA	Series A–Late Stage	—	+ Add to CRM
UR Urania Ventures HHMW2 people	88🔒	Berlin	DE	Seed–Late Stage	—	+ Add to CRM
SP Split Rock Partners DSJSMGSZ4 people · Leads rounds	88🔒	Eden Prairie	US	Seed–Late Stage	$2M – $40M	+ Add to CRM
FL Flying L Partners WLACMLRL5 people	88🔒	—		Late Stage	—	+ Add to CRM
WA WAMEX Private Equity CWEWABJA5 people	88🔒	Mexico City	MX	Growth–Late Stage	—	+ Add to CRM
HB HBM Healthcare Investments DEDRDSHP7 people	88🔒	Zug	CH	Growth–Late Stage	—	+ Add to CRM
RO Rosetta Capital Ltd. JHKMMFDL7 people	88🔒	Oxford	GB	Series A–Late Stage	—	+ Add to CRM
FL Flintera SVRUND3 people · Leads rounds	88🔒	—		Seed–Late Stage	$10M – $60M	+ Add to CRM
MI Mithera Capital DLECMFRP6 people	88🔒	Seattle	US	Seed–Late Stage	—	+ Add to CRM
YU Yukon Capital Partners ASTA2 people · Leads rounds	88🔒	Tokyo	JP	Growth–Late Stage	—	+ Add to CRM
DE Development Bank of Wales BCCRCGMO10 people	88🔒	Cardiff	GB	Pre-Seed–Late Stage	$12.7K – $12.7M	+ Add to CRM
FL Flint Capital AGSGDS3 people · Follows rounds	88🔒	Boston	US	Pre-Seed–Late Stage	$50K – $10M	+ Add to CRM
GO Gore Range Capital CNERHC3 people	88🔒	Southlake	US	Seed–Late Stage	$500K – $5M	+ Add to CRM
DA Daybreak Partners ND1 person	88🔒	—		Pre-Seed–Late Stage	—	+ Add to CRM
ME Med-Fine Capital AYALJZSS7 people · Follows rounds	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
MU Muirwoods Ventures	88🔒	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
SE Seido Capital OBTRPE3 people · Leads rounds	88🔒	Brussels	BE	Pre-Seed–Late Stage	$270K – $2.7M	+ Add to CRM
SA Sagitta Family Office FFMBAHKM5 people	88🔒	Copenhagen	DK	Growth–Late Stage	—	+ Add to CRM
SA Samara Asset Group PLCAMNJC5 people	88🔒	Birkirkara	MT	Pre-Seed–Late Stage	—	+ Add to CRM
H. H.I.G. BioHealth Partners SMTTBSDB6 people	88🔒	—		Growth–Late Stage	—	+ Add to CRM

HBM Partners

ZugPre-Seed–Late Stage$5M – $50M

DDDUFDFD5 people

Health2047 Capital Partners LLC

Menlo ParkSeed–Late Stage

DGGCRBRL5 people

Mubadala Capital

LondonSeries A–Late Stage$1M – $50M

KACGJEMJ5 people

NewMargin Ventures

ShanghaiPre-Seed–Late Stage$425K – $200M

YHCTHHHK5 people

Sectoral Asset Management

MontrealSeries A–Late Stage

MSFBMMCP8 people

Urania Ventures

BerlinSeed–Late Stage

HHMW2 people

Split Rock Partners

Eden PrairieSeed–Late Stage$2M – $40M

DSJSMGSZ4 people

Flying L Partners

Late Stage

WLACMLRL5 people

WAMEX Private Equity

Mexico CityGrowth–Late Stage

CWEWABJA5 people

HBM Healthcare Investments

ZugGrowth–Late Stage

DEDRDSHP7 people

Rosetta Capital Ltd.

OxfordSeries A–Late Stage

JHKMMFDL7 people

Flintera

Seed–Late Stage$10M – $60M

SVRUND3 people

Mithera Capital

SeattleSeed–Late Stage

DLECMFRP6 people

Yukon Capital Partners

TokyoGrowth–Late Stage

ASTA2 people

Development Bank of Wales

CardiffPre-Seed–Late Stage$12.7K – $12.7M

BCCRCGMO10 people

Flint Capital

BostonPre-Seed–Late Stage$50K – $10M

AGSGDS3 people

Gore Range Capital

SouthlakeSeed–Late Stage$500K – $5M

CNERHC3 people

Daybreak Partners

Pre-Seed–Late Stage

ND1 person

Med-Fine Capital

ShanghaiSeed–Late Stage

AYALJZSS7 people

Muirwoods Ventures

SeoulSeed–Late Stage

Seido Capital

BrusselsPre-Seed–Late Stage$270K – $2.7M

OBTRPE3 people

Sagitta Family Office

CopenhagenGrowth–Late Stage

FFMBAHKM5 people

Samara Asset Group

BirkirkaraPre-Seed–Late Stage

PLCAMNJC5 people

H.I.G. BioHealth Partners

Growth–Late Stage

SMTTBSDB6 people

Data sourced from public filings and firms' own websites — see our methodology.